Navigation Links
Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/19/2008

d and met with National Advisory Board for Cethromycin consisting

of thought leaders in the area of respiratory tract infections and

antibiotic therapies;

-- Granted Orphan Drug Designation by the FDA for ALS-357 in the topical

treatment of metastatic melanoma; and

-- Advanced development of ALS-357: manufactured clinical supplies and

submitted the protocol to the Northwestern University Institutional

Review Board (IRB) for the planned Phase I/II melanoma program.

Cethromycin Objectives for 2008

-- Attend FDA Anti-Infectives Advisory Committee meeting discussing

non-inferiority margins in CAP clinical trials scheduled for

April 1 and 2, 2008 and provide management's understanding of the

Advisory Committee meeting to investors via conference call on

April 3, 2008.

-- Conduct meeting with FDA on April 7, 2008 to discuss the anticipated

NDA submission in CAP and provide summary of outcome to investors via

conference call on April 10, 2008.

-- Incorporate guidance from April 1-2 FDA Advisory Committee meeting and

April 7 Advanced Life Sciences meeting with FDA to complete NDA

submission activities for cethromycin as a treatment for CAP;

-- Finalize negotiations with potential commercial partners for

cethromycin;

-- Continue collaborations with the National Institute of Allergy and

Infectious Diseases (NIAID) and The U.S. Army Medical Research

Institute for Infectious Diseases (USAMRIID) to explore cethromycin's

activity against high-priority bioterror agents for its use as a broad

spectrum countermeasure; and

-- Present cethromycin clinical data at ICAAC in the Fall.

Financial Guidance for 2008

Advanced Life Sciences expects its 2008 cash requirements excluding milestone payments that become due upon NDA filing to f
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Ashland, VA (PRWEB) March 06, 2015 ... of sodium hydroxide concentration by utilizing laboratory refractometers. ... soda) is used in producing a variety of products ... strong base is a staple of the chemical industry; ... to petroleum – and nearly everything in between. ...
(Date:3/5/2015)... SAN FRANCISCO , March 5, 2015  Twelve ... two-day, six-way kidney paired donation transplant at California Pacific ... Physicians here believe this procedure will be the ... West Coast and the largest conducted in the 44-year ... procedure today and tomorrow began with an altruistic donor ...
(Date:3/5/2015)... 05, 2015 BioPlus Specialty Pharmacy (BioPlus) ... of Vice President of Managed Care. In this role, ... one of the nation’s leading specialty pharmacies. , Damm, ... years of specialty pharmacy and biotech experience to his ... Pharmaceuticals, Vertex Pharmaceuticals, and Pfizer. Prior to working in ...
(Date:3/5/2015)... , March 5, 2015  UBM Medica ... , a leading online community to help oncologists ... the newest information available regarding the use of ... kidney cancer. March is National ... very few effective adjuvant treatment options for renal ...
Breaking Biology Technology:Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 2Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 3Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 4BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2OncoTherapy Network Highlights Kidney Cancer Awareness Month 2OncoTherapy Network Highlights Kidney Cancer Awareness Month 3
... recently participated in a roundtable discussion with HR executives ... talent management and resourcing strategies for elite multinational firms. ... how to make the work place and the workforce ... to make sure that companies always have the right ...
... its release of GroupWise Migrator for Exchange Version 2.2, ... of server and desktop data from Novell GroupWise to ... for Exchange could convert mail, archives, personal address books, ... Exchange. The new version adds the ability to migrate ...
... The time has come to reexamine the federal policy on ... itself at the center of this debate, because our state ... In 1998, Dr. Jamie Thomson at the University ... the first time, successfully isolated stem cells from human embryos ...
Cached Biology Technology:Stuck in Talent Gridlock 2Stuck in Talent Gridlock 3Wingra Technologies releases new e-mail-message migration software 2Gov. Doyle comments on unlocking the power of power of stem cell research 2Gov. Doyle comments on unlocking the power of power of stem cell research 3
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... French colonial-style exterior of the National Cancer Hospital in Hanoi, ... hospitals crowded wards, treatment rooms and corridors, doctors are struggling ... the disease is winning. Each year in this country ... cancer and another 150,000 new cases are diagnosed. Figures are ...
... United States die every year from uncontrolled infections of ... pushing the boundaries of molecular science to find new ... measure of an immune system protein within 24 hours ... can predict survival in children, yielding a powerful tool ...
... in Germany have discovered that methadone, an agent used ... power against leukemia cells, including treatment resistant forms of ... August 1 issue of Cancer Research , a ... that methadone holds promise as a new therapy for ...
Cached Biology News:In Vietnam, alongside progress, a battle for life 2In Vietnam, alongside progress, a battle for life 3Immune system protein accurate predictor of survival in pediatric septic shock 2Immune system protein accurate predictor of survival in pediatric septic shock 3Lab study shows methadone breaks resistance in untreatable forms of leukemia 2
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
...
Request Info...
...
Biology Products: